| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |